Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sharon

Showing results (151-160 of 200) with videos related to

Pageof 20
Sort By:
Cancer Research|June 19, 2008
Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cellsKaren D Cowden Dahl, Jaime Symowicz, Yan Ning, et al.
The Journal of Biological Chemistry|July 13, 2004
Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysisHidayatullah G Munshi, Yi I Wu, Subhendu Mukhopadhyay, et al.
Cancer Research|March 3, 2007
Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cellsJaime Symowicz, Brian P Adley, Kara J Gleason, et al.
The American Journal of Pathology|January 10, 2015
Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome AtlasDaniel L Miller, J Wade Davis, Kristen H Taylor, et al.
The Journal of Biological Chemistry|February 4, 2016
Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell CarcinomaJeff J Johnson, Daniel L Miller, Rong Jiang, et al.
The Journal of Physical Chemistry Letters|May 24, 2023
Stability of 20S Proteasome Configurations: Preopening the Axial GateLucas W Henderson, Edie M Sharon, Amit K S Gautam, et al.
Disease Models & Mechanisms|September 27, 2018
Modeling the effect of ascites-induced compression on ovarian cancer multicellular aggregatesYuliya Klymenko, Rebecca B Wates, Holly Weiss-Bilka, et al.
International Journal of Cancer|April 22, 2009
Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasionMaria V Barbolina, Brian P Adley, David L Kelly, et al.
Cancer Treatment and Research|September 19, 2009
Microenvironmental regulation of ovarian cancer metastasisMaria V Barbolina, Natalie M Moss, Suzanne D Westfall, et al.
Journal of Psychiatric Research|February 8, 2022
Maternal fear of COVID-19 and prevalence of postnatal depression symptoms, risk and protective factorsH Gluska, N Shiffman, Y Mayer, et al.
Pageof 20

Showing results (151-160 of 200) with videos related to

Sort By:
Pageof 20
Cancer Research|June 19, 2008
Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cellsKaren D Cowden Dahl, Jaime Symowicz, Yan Ning, et al.
The Journal of Biological Chemistry|July 13, 2004
Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysisHidayatullah G Munshi, Yi I Wu, Subhendu Mukhopadhyay, et al.
Cancer Research|March 3, 2007
Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cellsJaime Symowicz, Brian P Adley, Kara J Gleason, et al.
The American Journal of Pathology|January 10, 2015
Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome AtlasDaniel L Miller, J Wade Davis, Kristen H Taylor, et al.
The Journal of Biological Chemistry|February 4, 2016
Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell CarcinomaJeff J Johnson, Daniel L Miller, Rong Jiang, et al.
The Journal of Physical Chemistry Letters|May 24, 2023
Stability of 20S Proteasome Configurations: Preopening the Axial GateLucas W Henderson, Edie M Sharon, Amit K S Gautam, et al.
Disease Models & Mechanisms|September 27, 2018
Modeling the effect of ascites-induced compression on ovarian cancer multicellular aggregatesYuliya Klymenko, Rebecca B Wates, Holly Weiss-Bilka, et al.
International Journal of Cancer|April 22, 2009
Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasionMaria V Barbolina, Brian P Adley, David L Kelly, et al.
Cancer Treatment and Research|September 19, 2009
Microenvironmental regulation of ovarian cancer metastasisMaria V Barbolina, Natalie M Moss, Suzanne D Westfall, et al.
Journal of Psychiatric Research|February 8, 2022
Maternal fear of COVID-19 and prevalence of postnatal depression symptoms, risk and protective factorsH Gluska, N Shiffman, Y Mayer, et al.
Pageof 20